Polyploidy mitigates the impact of DNA damage while simultaneously bearing its burden
Polyploidy is frequently enhanced under pathological conditions, such as tissue injury and cancer in humans. Polyploidization is critically involved in cancer evolution, including cancer initiation and the acquisition of drug resistance. However, the effect of polyploidy on cell fate remains unclear. In this study, we explored the effects of polyploidization on cellular responses to DNA damage and cell cycle progression. Through various comparisons based on ploidy stratifications of cultured cells, we found that polyploidization and the accumulation of genomic DNA damage mutually induce each other, resulting in polyploid cells consistently containing more genomic DNA damage than diploid cells under both physiological and stress conditions. Notably, despite substantial DNA damage, polyploid cells demonstrated a higher tolerance to its impact, exhibiting delayed cell cycle arrest and reduced secretion of inflammatory cytokines associated with DNA damage-induced senescence. Consistently, in mice with ploidy tracing, hepatocytes with high ploidy appeared to potentially persist in the damaged liver, while being susceptible to DNA damage. Polyploidy acts as a reservoir of genomic damage by mitigating the impact of DNA damage, while simultaneously enhancing its accumulation.
Authors
- Kazuki Hayashi
- Tomonori Matsumoto (ORCID: https://orcid.org/0000-0003-4483-2178)
- Takako Yamashita
- Hidenori Inohara (ORCID: https://orcid.org/0000-0003-4473-1203)
- Teruaki Kitano
- Yoshiyuki Harada
- Eiji Hara (ORCID: https://orcid.org/0000-0001-7821-3960)
- Takahito Fukusumi (ORCID: https://orcid.org/0009-0002-1857-7548)
- Masahiro Wakita
- Yuta Ogawa
- K Horisaka
Institutions
- Kyoto University (JP)
- Kobe University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Cell Death Discovery
- Published
- 2024-10-13
- DOI
- https://doi.org/10.1038/s41420-024-02206-w
- Citations
- 13
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Uehara Memorial Foundation
- Japan Agency for Medical Research and Development
- Inamori Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Research Institute for Microbial Diseases, Osaka University